DTIL Relative Valuation
DTIL's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, DTIL is overvalued; if below, it's undervalued.
Historical Valuation
Precision BioSciences Inc (DTIL) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -2.53. The fair price of Precision BioSciences Inc (DTIL) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price：5.03
Fair
-1.58
PE
1Y
3Y
5Y
Trailing
Forward
-1.74
EV/EBITDA
Precision BioSciences Inc. (DTIL) has a current EV/EBITDA of -1.74. The 5-year average EV/EBITDA is -0.79. The thresholds are as follows: Strongly Undervalued below -9.82, Undervalued between -9.82 and -5.30, Fairly Valued between 3.73 and -5.30, Overvalued between 3.73 and 8.25, and Strongly Overvalued above 8.25. The current Forward EV/EBITDA of -1.74 falls within the Historic Trend Line -Fairly Valued range.
-1.43
EV/EBIT
Precision BioSciences Inc. (DTIL) has a current EV/EBIT of -1.43. The 5-year average EV/EBIT is -0.94. The thresholds are as follows: Strongly Undervalued below -7.23, Undervalued between -7.23 and -4.08, Fairly Valued between 2.20 and -4.08, Overvalued between 2.20 and 5.35, and Strongly Overvalued above 5.35. The current Forward EV/EBIT of -1.43 falls within the Historic Trend Line -Fairly Valued range.
7.85
PS
Precision BioSciences Inc. (DTIL) has a current PS of 7.85. The 5-year average PS is 6.55. The thresholds are as follows: Strongly Undervalued below -8.01, Undervalued between -8.01 and -0.73, Fairly Valued between 13.83 and -0.73, Overvalued between 13.83 and 21.11, and Strongly Overvalued above 21.11. The current Forward PS of 7.85 falls within the Historic Trend Line -Fairly Valued range.
-4.47
P/OCF
Precision BioSciences Inc. (DTIL) has a current P/OCF of -4.47. The 5-year average P/OCF is -4.64. The thresholds are as follows: Strongly Undervalued below -19.48, Undervalued between -19.48 and -12.06, Fairly Valued between 2.79 and -12.06, Overvalued between 2.79 and 10.21, and Strongly Overvalued above 10.21. The current Forward P/OCF of -4.47 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/FCF
Precision BioSciences Inc. (DTIL) has a current P/FCF of 0.00. The 5-year average P/FCF is -26.07. The thresholds are as follows: Strongly Undervalued below -368.93, Undervalued between -368.93 and -197.50, Fairly Valued between 145.35 and -197.50, Overvalued between 145.35 and 316.78, and Strongly Overvalued above 316.78. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
Precision BioSciences Inc (DTIL) has a current Price-to-Book (P/B) ratio of 3.68. Compared to its 3-year average P/B ratio of 1.74 , the current P/B ratio is approximately 111.44% higher. Relative to its 5-year average P/B ratio of 3.32, the current P/B ratio is about 10.60% higher. Precision BioSciences Inc (DTIL) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -107.69%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -74.74% , the current FCF yield is about -100.00% lower.
3.65
P/B
Median3y
1.74
Median5y
3.32
-60.29
FCF Yield
Median3y
-107.69
Median5y
-74.74
Competitors Valuation Multiple
The average P/S ratio for DTIL's competitors is 0.00, providing a benchmark for relative valuation. Precision BioSciences Inc Corp (DTIL) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of -97.74%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of DTIL increased by 31.76% over the past 1 year. The primary factor behind the change was an decrease in Margin Expansion from -2.85K to -167.48K.
The secondary factor is the Revenue Growth, contributed -97.74%to the performance.
Overall, the performance of DTIL in the past 1 year is driven by Margin Expansion. Which is more sustainable.
People Also Watch
FAQ
Is Precision BioSciences Inc (DTIL) currently overvalued or undervalued?
What is Precision BioSciences Inc (DTIL) fair value?
How does DTIL's valuation metrics compare to the industry average?
What is the current P/B ratio for Precision BioSciences Inc (DTIL) as of Dec 05 2025?
What is the current FCF Yield for Precision BioSciences Inc (DTIL) as of Dec 05 2025?
What is the current Forward P/E ratio for Precision BioSciences Inc (DTIL) as of Dec 05 2025?